Abstract
[Display omitted]
•Field studies were conducted in horses, cattle and goats using BioWorma®.•The studies were conducted in Australia across a range of climatic zones / seasons.•Significant reductions in larvae on pasture were obtained for each animal species.•Main worm species were those of commercial importance to horses, cattle and goats.
A series of placebo-controlled trials were conducted in horses, cattle and goats in different seasons and bioclimatic regions of New South Wales and Queensland, Australia, to evaluate the ability of BioWorma®, a feed supplement containing the spores of Duddingtonia flagrans IAH 1297, to reduce the larval development of parasitic gastrointestinal nematodes (GIN) and their subsequent migration from faeces onto the surrounding pasture.
In each trial, faeces were collected from animals harbouring a burden of nematode parasites following a period of supplementation with a placebo and again after supplementation with BioWorma. The faeces were manually placed onto pasture plots at one or two distinct geographical sites and the effect of treatment was determined by subsequent monitoring the numbers of parasitic larvae on the pasture surrounding the faecal pats at two weekly intervals over an eight week period. The results for these studies showed that administration of BioWorma at a minimum daily dose of 3 × 104 spores/kg bodyweight reduced parasite larvae in the pasture surrounding the faeces by 53–99 % over an eight week post treatment period in horses, cattle and goats in a range of bioclimatic zones and in different seasons.
Overall, the studies with BioWorma show substantial reductions in GIN infectivity of pasture surrounding faeces of treated horses, cattle and goats (P < 0.05). Results indicate that the use of BioWorma in these host species would lead to decreased levels of GIN infection in animals grazing pasture when this product is used and would provide an alternative means of controlling parasitic nematodes.